Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of High Potency API
Revenue, means the sales value of High Potency API
This report studies sales (consumption) of High Potency API in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Pfizer
Novartis International
Sanofi
Boehringer Ingelheim
Bristol-Myers Squibb
Teva Pharmaceutical
Eli Lilly and Company
GlaxoSmithKline
Merck & Co
AbbVie
Johnson & Johnson
Bayer
Mylan
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of High Potency API in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Synthetic HPAPIs
Biotech HPAPIs
Split by application, this report focuses on sales, market share and growth rate of High Potency API in each application, can be divided into
Oncology
Hormonal Disorders
Glaucoma
Other
Europe High Potency API Market Report 2017
1 High Potency API Overview
1.1 Product Overview and Scope of High Potency API
1.2 Classification of High Potency API
1.2.1 Synthetic HPAPIs
1.2.2 Biotech HPAPIs
1.3 Application of High Potency API
1.3.1 Oncology
1.3.2 Hormonal Disorders
1.3.3 Glaucoma
1.3.4 Other
1.4 High Potency API Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of High Potency API (2012-2022)
1.5.1 Europe High Potency API Sales and Growth Rate (2012-2022)
1.5.2 Europe High Potency API Revenue and Growth Rate (2012-2022)
2 Europe High Potency API by Manufacturers, Type and Application
2.1 Europe High Potency API Market Competition by Manufacturers
2.1.1 Europe High Potency API Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe High Potency API Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe High Potency API (Volume and Value) by Type
2.2.1 Europe High Potency API Sales and Market Share by Type (2012-2017)
2.2.2 Europe High Potency API Revenue and Market Share by Type (2012-2017)
2.3 Europe High Potency API (Volume and Value) by Countries
2.3.1 Europe High Potency API Sales and Market Share by Countries (2012-2017)
2.3.2 Europe High Potency API Revenue and Market Share by Countries (2012-2017)
2.4 Europe High Potency API (Volume) by Application
3 Germany High Potency API (Volume, Value and Sales Price)
3.1 Germany High Potency API Sales and Value (2012-2017)
3.1.1 Germany High Potency API Sales and Growth Rate (2012-2017)
3.1.2 Germany High Potency API Revenue and Growth Rate (2012-2017)
3.1.3 Germany High Potency API Sales Price Trend (2012-2017)
3.2 Germany High Potency API Sales and Market Share by Manufacturers
3.3 Germany High Potency API Sales and Market Share by Type
3.4 Germany High Potency API Sales and Market Share by Application
4 France High Potency API (Volume, Value and Sales Price)
4.1 France High Potency API Sales and Value (2012-2017)
4.1.1 France High Potency API Sales and Growth Rate (2012-2017)
4.1.2 France High Potency API Revenue and Growth Rate (2012-2017)
4.1.4 France High Potency API Sales Price Trend (2012-2017)
4.2 France High Potency API Sales and Market Share by Manufacturers
4.3 France High Potency API Sales and Market Share by Type
4.4 France High Potency API Sales and Market Share by Application
5 UK High Potency API (Volume, Value and Sales Price)
5.1 UK High Potency API Sales and Value (2012-2017)
5.1.1 UK High Potency API Sales and Growth Rate (2012-2017)
5.1.2 UK High Potency API Revenue and Growth Rate (2012-2017)
5.1.5 UK High Potency API Sales Price Trend (2012-2017)
5.2 UK High Potency API Sales and Market Share by Manufacturers
5.3 UK High Potency API Sales and Market Share by Type
5.4 UK High Potency API Sales and Market Share by Application
6 Russia High Potency API (Volume, Value and Sales Price)
6.1 Russia High Potency API Sales and Value (2012-2017)
6.1.1 Russia High Potency API Sales and Growth Rate (2012-2017)
6.1.2 Russia High Potency API Revenue and Growth Rate (2012-2017)
6.1.6 Russia High Potency API Sales Price Trend (2012-2017)
6.2 Russia High Potency API Sales and Market Share by Manufacturers
6.3 Russia High Potency API Sales and Market Share by Type
6.4 Russia High Potency API Sales and Market Share by Application
7 Italy High Potency API (Volume, Value and Sales Price)
7.1 Italy High Potency API Sales and Value (2012-2017)
7.1.1 Italy High Potency API Sales and Growth Rate (2012-2017)
7.1.2 Italy High Potency API Revenue and Growth Rate (2012-2017)
7.1.7 Italy High Potency API Sales Price Trend (2012-2017)
7.2 Italy High Potency API Sales and Market Share by Manufacturers
7.3 Italy High Potency API Sales and Market Share by Type
7.4 Italy High Potency API Sales and Market Share by Application
8 Spain High Potency API (Volume, Value and Sales Price)
8.1 Spain High Potency API Sales and Value (2012-2017)
8.1.1 Spain High Potency API Sales and Growth Rate (2012-2017)
8.1.2 Spain High Potency API Revenue and Growth Rate (2012-2017)
8.1.8 Spain High Potency API Sales Price Trend (2012-2017)
8.2 Spain High Potency API Sales and Market Share by Manufacturers
8.3 Spain High Potency API Sales and Market Share by Type
8.4 Spain High Potency API Sales and Market Share by Application
9 Benelux High Potency API (Volume, Value and Sales Price)
9.1 Benelux High Potency API Sales and Value (2012-2017)
9.1.1 Benelux High Potency API Sales and Growth Rate (2012-2017)
9.1.2 Benelux High Potency API Revenue and Growth Rate (2012-2017)
9.1.9 Benelux High Potency API Sales Price Trend (2012-2017)
9.2 Benelux High Potency API Sales and Market Share by Manufacturers
9.3 Benelux High Potency API Sales and Market Share by Type
9.4 Benelux High Potency API Sales and Market Share by Application
10 Europe High Potency API Manufacturers Analysis
10.1 Pfizer
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 High Potency API Product Type, Application and Specification
10.1.2.1 Synthetic HPAPIs
10.1.2.2 Biotech HPAPIs
10.1.3 Pfizer High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Novartis International
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 High Potency API Product Type, Application and Specification
10.2.2.1 Synthetic HPAPIs
10.2.2.2 Biotech HPAPIs
10.2.3 Novartis International High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Sanofi
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 High Potency API Product Type, Application and Specification
10.3.2.1 Synthetic HPAPIs
10.3.2.2 Biotech HPAPIs
10.3.3 Sanofi High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Boehringer Ingelheim
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 High Potency API Product Type, Application and Specification
10.4.2.1 Synthetic HPAPIs
10.4.2.2 Biotech HPAPIs
10.4.3 Boehringer Ingelheim High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Bristol-Myers Squibb
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 High Potency API Product Type, Application and Specification
10.5.2.1 Synthetic HPAPIs
10.5.2.2 Biotech HPAPIs
10.5.3 Bristol-Myers Squibb High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Teva Pharmaceutical
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 High Potency API Product Type, Application and Specification
10.6.2.1 Synthetic HPAPIs
10.6.2.2 Biotech HPAPIs
10.6.3 Teva Pharmaceutical High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Eli Lilly and Company
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 High Potency API Product Type, Application and Specification
10.7.2.1 Synthetic HPAPIs
10.7.2.2 Biotech HPAPIs
10.7.3 Eli Lilly and Company High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 GlaxoSmithKline
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 High Potency API Product Type, Application and Specification
10.8.2.1 Synthetic HPAPIs
10.8.2.2 Biotech HPAPIs
10.8.3 GlaxoSmithKline High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Merck & Co
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 High Potency API Product Type, Application and Specification
10.9.2.1 Synthetic HPAPIs
10.9.2.2 Biotech HPAPIs
10.9.3 Merck & Co High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 AbbVie
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 High Potency API Product Type, Application and Specification
10.10.2.1 Synthetic HPAPIs
10.10.2.2 Biotech HPAPIs
10.10.3 AbbVie High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Johnson & Johnson
10.12 Bayer
10.13 Mylan
11 High Potency API Manufacturing Cost Analysis
11.1 High Potency API Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of High Potency API
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 High Potency API Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of High Potency API Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe High Potency API Market Forecast (2017-2022)
14.1 Germany High Potency API Sales Forecast (2017-2022)
14.2 France High Potency API Sales Forecast (2017-2022)
14.3 UK High Potency API Sales Forecast (2017-2022)
14.4 Russia High Potency API Sales Forecast (2017-2022)
14.5 Italy High Potency API Sales Forecast (2017-2022)
14.6 Spain High Potency API Sales Forecast (2017-2022)
14.7 Benelux High Potency API Sales Forecast (2017-2022)
14.8 Europe High Potency API Sales Forecast by Type (2017-2022)
14.9 Europe High Potency API Sales Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of High Potency API
Table Classification of High Potency API
Figure Europe Sales Market Share of High Potency API by Type in 2015
Figure Synthetic HPAPIs Picture
Figure Biotech HPAPIs Picture
Table Application of High Potency API
Figure Europe Sales Market Share of High Potency API by Application in 2015
Figure Oncology Examples
Figure Hormonal Disorders Examples
Figure Glaucoma Examples
Figure Other Examples
Figure Germany High Potency API Revenue and Growth Rate (2012-2022)
Figure France High Potency API Revenue and Growth Rate (2012-2022)
Figure UK High Potency API Revenue and Growth Rate (2012-2022)
Figure Russia High Potency API Revenue and Growth Rate (2012-2022)
Figure Italy High Potency API Revenue and Growth Rate (2012-2022)
Figure Spain High Potency API Revenue and Growth Rate (2012-2022)
Figure Benelux High Potency API Revenue and Growth Rate (2012-2022)
Figure Europe High Potency API Sales and Growth Rate (2012-2022)
Figure Europe High Potency API Revenue and Growth Rate (2012-2022)
Table Europe High Potency API Sales of Key Manufacturers (2015 and 2016)
Table Europe High Potency API Sales Share by Manufacturers (2015 and 2016)
Figure 2015 High Potency API Sales Share by Manufacturers
Figure 2016 High Potency API Sales Share by Manufacturers
Table Europe High Potency API Revenue by Manufacturers (2015 and 2016)
Table Europe High Potency API Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe High Potency API Revenue Share by Manufacturers
Table 2016 Europe High Potency API Revenue Share by Manufacturers
Table Europe High Potency API Sales and Market Share by Type (2012-2017)
Table Europe High Potency API Sales Share by Type (2012-2017)
Figure Sales Market Share of High Potency API by Type (2012-2017)
Figure Europe High Potency API Sales Growth Rate by Type (2012-2017)
Table Europe High Potency API Revenue and Market Share by Type (2012-2017)
Table Europe High Potency API Revenue Share by Type (2012-2017)
Figure Revenue Market Share of High Potency API by Type (2012-2017)
Figure Europe High Potency API Revenue Growth Rate by Type (2012-2017)
Table Europe High Potency API Sales and Market Share by Countries (2012-2017)
Table Europe High Potency API Sales Share by Countries (2012-2017)
Figure Sales Market Share of High Potency API by Countries (2012-2017)
Table Europe High Potency API Revenue and Market Share by Countries (2012-2017)
Table Europe High Potency API Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of High Potency API by Countries (2012-2017)
Table Europe High Potency API Sales and Market Share by Application (2012-2017)
Table Europe High Potency API Sales Share by Application (2012-2017)
Figure Sales Market Share of High Potency API by Application (2012-2017)
Figure Germany High Potency API Sales and Growth Rate (2012-2017)
Figure Germany High Potency API Revenue and Growth Rate (2012-2017)
Figure Germany High Potency API Sales Price Trend (2012-2017)
Table Germany High Potency API Sales by Manufacturers (2015 and 2016)
Table Germany High Potency API Market Share by Manufacturers (2015 and 2016)
Table Germany High Potency API Sales by Type (2015 and 2016)
Table Germany High Potency API Market Share by Type (2015 and 2016)
Table Germany High Potency API Sales by Application (2015 and 2016)
Table Germany High Potency API Market Share by Application (2015 and 2016)
Figure France High Potency API Sales and Growth Rate (2012-2017)
Figure France High Potency API Revenue and Growth Rate (2012-2017)
Figure France High Potency API Sales Price Trend (2012-2017)
Table France High Potency API Sales by Manufacturers (2015 and 2016)
Table France High Potency API Market Share by Manufacturers (2015 and 2016)
Table France High Potency API Sales by Type (2015 and 2016)
Table France High Potency API Market Share by Type (2015 and 2016)
Table France High Potency API Sales by Application (2015 and 2016)
Table France High Potency API Market Share by Application (2015 and 2016)
Figure UK High Potency API Sales and Growth Rate (2012-2017)
Figure UK High Potency API Revenue and Growth Rate (2012-2017)
Figure UK High Potency API Sales Price Trend (2012-2017)
Table UK High Potency API Sales by Manufacturers (2015 and 2016)
Table UK High Potency API Market Share by Manufacturers (2015 and 2016)
Table UK High Potency API Sales by Type (2015 and 2016)
Table UK High Potency API Market Share by Type (2015 and 2016)
Table UK High Potency API Sales by Application (2015 and 2016)
Table UK High Potency API Market Share by Application (2015 and 2016)
Figure Russia High Potency API Sales and Growth Rate (2012-2017)
Figure Russia High Potency API Revenue and Growth Rate (2012-2017)
Figure Russia High Potency API Sales Price Trend (2012-2017)
Table Russia High Potency API Sales by Manufacturers (2015 and 2016)
Table Russia High Potency API Market Share by Manufacturers (2015 and 2016)
Table Russia High Potency API Sales by Type (2015 and 2016)
Table Russia High Potency API Market Share by Type (2015 and 2016)
Table Russia High Potency API Sales by Application (2015 and 2016)
Table Russia High Potency API Market Share by Application (2015 and 2016)
Figure Italy High Potency API Sales and Growth Rate (2012-2017)
Figure Italy High Potency API Revenue and Growth Rate (2012-2017)
Figure Italy High Potency API Sales Price Trend (2012-2017)
Table Italy High Potency API Sales by Manufacturers (2015 and 2016)
Table Italy High Potency API Market Share by Manufacturers (2015 and 2016)
Table Italy High Potency API Sales by Type (2015 and 2016)
Table Italy High Potency API Market Share by Type (2015 and 2016)
Table Italy High Potency API Sales by Application (2015 and 2016)
Table Italy High Potency API Market Share by Application (2015 and 2016)
Figure Spain High Potency API Sales and Growth Rate (2012-2017)
Figure Spain High Potency API Revenue and Growth Rate (2012-2017)
Figure Spain High Potency API Sales Price Trend (2012-2017)
Table Spain High Potency API Sales by Manufacturers (2015 and 2016)
Table Spain High Potency API Market Share by Manufacturers (2015 and 2016)
Table Spain High Potency API Sales by Type (2015 and 2016)
Table Spain High Potency API Market Share by Type (2015 and 2016)
Table Spain High Potency API Sales by Application (2015 and 2016)
Table Spain High Potency API Market Share by Application (2015 and 2016)
Figure Benelux High Potency API Sales and Growth Rate (2012-2017)
Figure Benelux High Potency API Revenue and Growth Rate (2012-2017)
Figure Benelux High Potency API Sales Price Trend (2012-2017)
Table Benelux High Potency API Sales by Manufacturers (2015 and 2016)
Table Benelux High Potency API Market Share by Manufacturers (2015 and 2016)
Table Benelux High Potency API Sales by Type (2015 and 2016)
Table Benelux High Potency API Market Share by Type (2015 and 2016)
Table Benelux High Potency API Sales by Application (2015 and 2016)
Table Benelux High Potency API Market Share by Application (2015 and 2016)
Table High Potency API Basic Information List
Table Pfizer High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer High Potency API Sales Market Share (2012-2017)
Table Novartis International Basic Information List
Table Novartis International High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis International High Potency API Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi High Potency API Sales Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim High Potency API Sales Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb High Potency API Sales Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information List
Table Teva Pharmaceutical High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Pharmaceutical High Potency API Sales Market Share (2012-2017)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly and Company High Potency API Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline High Potency API Sales Market Share (2012-2017)
Table Merck & Co Basic Information List
Table Merck & Co High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck & Co High Potency API Sales Market Share (2012-2017)
Table AbbVie Basic Information List
Table AbbVie High Potency API Sales, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie High Potency API Sales Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Bayer Basic Information List
Table Mylan Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of High Potency API
Figure Manufacturing Process Analysis of High Potency API
Figure High Potency API Industrial Chain Analysis
Table Raw Materials Sources of High Potency API Major Manufacturers in 2015
Table Major Buyers of High Potency API
Table Distributors/Traders List
Figure Germany High Potency API Sales and Growth Rate Forecast (2017-2022)
Figure Germany High Potency API Revenue and Growth Rate Forecast (2017-2022)
Figure France High Potency API Sales and Growth Rate Forecast (2017-2022)
Figure France High Potency API Revenue and Growth Rate Forecast (2017-2022)
Figure UK High Potency API Sales and Growth Rate Forecast (2017-2022)
Figure UK High Potency API Revenue and Growth Rate Forecast (2017-2022)
Figure Russia High Potency API Sales and Growth Rate Forecast (2017-2022)
Figure Russia High Potency API Revenue and Growth Rate Forecast (2017-2022)
Figure Italy High Potency API Sales and Growth Rate Forecast (2017-2022)
Figure Italy High Potency API Revenue and Growth Rate Forecast (2017-2022)
Figure Spain High Potency API Sales and Growth Rate Forecast (2017-2022)
Figure Spain High Potency API Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux High Potency API Sales and Growth Rate Forecast (2017-2022)
Figure Benelux High Potency API Revenue and Growth Rate Forecast (2017-2022)
Table Europe High Potency API Sales Forecast by Type (2017-2022)
Table Europe High Potency API Sales Forecast by Application (2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...